Trial intelligence / Profile preview

JMS-1: Doxazosin for Morning Hypertension

NCT00285519Phase 4Completed

Sponsor
Japan Heart Foundation
Start
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of doxazosin in hypertension (HTN), sponsored by Japan Heart Foundation. Started Aug 2003; status: completed.

02

Drugs

doxazosin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00285519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00285519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call